We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Reaps Benefits From Toprol-XL Supply Issues
AstraZeneca Reaps Benefits From Toprol-XL Supply Issues
May 1, 2009
U.S. sales of AstraZeneca’s Toprol-XL franchise more than doubled this past quarter as quality control issues hampered generic competitors, the company reports.